Literature DB >> 32613202

Dividing the Emergency Department into Red, Yellow, and Green Zones to Control COVID-19 Infection; a Letter to Editor.

Chee-Fah Chong1,2.   

Abstract

COVID-19, in certain respects, can be viewed as a CBRN (chemical, biological, radiological, or nuclear) event due to being a consequence of SARS-CoV2 virus (the "contaminant"). We, thus, reorganized our emergency department (ED) into 3 distinct zones (red, yellow, and green) for the purpose of infection control. Patients with high or medium risk of COVID-19 infection are managed in the red zones. Low-risk patients are managed in the yellow zones. All patients are prohibited to enter the green zones. Green zones are used by healthcare providers (HCPs) for personal protective equipment (PPE) donning, inventory, planning, and dining. Only HCPs who work in the red zones are required to use full level PPE (aerosol precaution). HCPs working in the yellow zones require less PPE (contact and droplet precaution). No PPE is required in the green zones. Establishing red, yellow, and green zones in the ED can be helpful in reducing cross-infections and minimizing demand for PPE.

Entities:  

Keywords:  Coronavirus Infections; Emergency Medical Services; Emergency Service; Health Facilities; Hospital; Infection Control

Year:  2020        PMID: 32613202      PMCID: PMC7305635     

Source DB:  PubMed          Journal:  Arch Acad Emerg Med        ISSN: 2645-4904


Dear Editor, Patients in our emergency department (ED) are divided into 3 groups according to their risk of COVID-19 infection. High-risk patients are those with positive TOCC (travel history, occupation, contact, cluster) who also have fever or respiratory symptoms. Persons under COVID-19 investigation (PUI) are also considered high-risk. Patients without TOCC, who have fever or respiratory symptoms, are considered medium-risk. Patients without TOCC who have no fever or respiratory symptoms are considered low-risk. COVID-19, in certain respects, can be viewed as a CBRN (chemical, biological, radiological, or nuclear) event (1) due to being a consequence of SARS-CoV2 virus (the “contaminant”). We, thus, reorganized our ED into 3 distinct zones: red, yellow, and green zones (Figure 1) for the purpose of infection control. Patients with high or medium risk of COVID-19 infection are managed in the red zones. Red zones include the outdoor triage tents and the negative-pressure isolation room. Low-risk patients are managed in the yellow zones. Yellow zones include the indoor triage, waiting room, consultation rooms, observation rooms, and nursing station. Green zones are used by healthcare providers (HCPs) for personal protective equipment (PPE) donning, inventory, planning, and dining. All patients are prohibited from entering the green zones.
Figure 1

Planimetric map showing different areas of the emergency department discriminated into red, yellow, and green zones

Our spatial separation strategy using red, yellow, and green zones is also helpful in PPE conservation (2, 3). Only HCPs who work in the red zones are required to use full level PPE (aerosol precaution: N95 respirator, gown, gloves, eye protection, apron). HCPs working in the yellow zones require less PPE (contact and droplet precaution: surgical mask, gown, gloves, eye protection). No PPE is required in the green zones. Contaminated PPE should be removed before entering the green zones. In conclusion, establishing red, yellow, and green zones in the ED can be helpful in reducing cross-infections and minimizing demand for PPE. Planimetric map showing different areas of the emergency department discriminated into red, yellow, and green zones
  3 in total

1.  Triage, monitoring, and treatment of mass casualty events involving chemical, biological, radiological, or nuclear agents.

Authors:  Aruna C Ramesh; S Kumar
Journal:  J Pharm Bioallied Sci       Date:  2010-07

2.  Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff.

Authors:  Jos H Verbeek; Blair Rajamaki; Sharea Ijaz; Riitta Sauni; Elaine Toomey; Bronagh Blackwood; Christina Tikka; Jani H Ruotsalainen; F Selcen Kilinc Balci
Journal:  Cochrane Database Syst Rev       Date:  2020-04-15

3.  Personal protective equipment and possible routes of airborne spread during the COVID-19 pandemic.

Authors:  J Brown; C Pope
Journal:  Anaesthesia       Date:  2020-04-26       Impact factor: 12.893

  3 in total
  3 in total

1.  COVID-19 convalescent plasma.

Authors:  Aaron A R Tobian; Claudia S Cohn; Beth H Shaz
Journal:  Blood       Date:  2022-07-21       Impact factor: 25.476

Review 2.  COVID-19 in Southeast Asia: current status and perspectives.

Authors:  Dinh-Toi Chu; Suong-Mai Vu Ngoc; Hue Vu Thi; Yen-Vy Nguyen Thi; Thuy-Tien Ho; Van-Thuan Hoang; Vijai Singh; Jaffar A Al-Tawfiq
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

3.  It's not always Occam's razor: The pivotal role of telemedicine in stroke patients amidst the COVID-19 pandemic.

Authors:  Talal Almas; Maryam Ehtesham; Uzair Malik; Vikneswaran Raj Nagarajan; Mahnoor Sukaina; Norah Alshareef; Ahlam Alzahrani; Suliman Abuhaimed; Yohan Porus Irani; Enaam Alzadjali; Eissa Sultan Alwheibi; Mhmod Kadom; Saif Khalid; Muhammad Shehryar; Khalid Muhammad Al Shumrani
Journal:  Ann Med Surg (Lond)       Date:  2022-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.